2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 118.742 | 135.702 | 147.579 | 114.820 | 125.341 | 110.358 | 143.275 | 142.945 | 155.119 | 181.877 |
Total Income - EUR | 118.759 | 135.702 | 147.579 | 143.499 | 125.341 | 111.155 | 143.275 | 142.945 | 155.119 | 181.877 |
Total Expenses - EUR | 104.481 | 130.422 | 146.247 | 177.136 | 121.564 | 97.959 | 127.876 | 137.371 | 145.615 | 167.093 |
Gross Profit/Loss - EUR | 14.278 | 5.280 | 1.332 | -33.636 | 3.777 | 13.197 | 15.399 | 5.574 | 9.504 | 14.784 |
Net Profit/Loss - EUR | 11.721 | 4.257 | 901 | -36.645 | 2.523 | 12.127 | 13.934 | 4.247 | 7.914 | 13.148 |
Employees | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Equifarm S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 4.172 | 3.408 | 2.665 | 0 | 0 | 862 | 1.203 | 776 |
Current Assets | 43.075 | 48.505 | 31.278 | 11.397 | 20.757 | 25.537 | 24.566 | 27.978 | 28.656 | 30.467 |
Inventories | 28.150 | 26.555 | 25.821 | 6.976 | 11.134 | 23.459 | 24.230 | 27.275 | 19.529 | 14.281 |
Receivables | 186 | 567 | 1.633 | 3.796 | 4.247 | 1.150 | 139 | 355 | 137 | 97 |
Cash | 14.739 | 21.382 | 3.824 | 625 | 5.376 | 928 | 197 | 348 | 8.990 | 16.090 |
Shareholders Funds | 12.011 | 16.368 | 1.556 | -36.592 | -33.397 | -20.623 | -6.299 | -1.912 | 5.996 | 15.192 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 31.064 | 32.137 | 33.895 | 51.398 | 56.819 | 46.160 | 30.865 | 30.752 | 23.864 | 16.052 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7500 - 7500" | |||||||||
CAEN Financial Year |
7500
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Equifarm S.r.l.